- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ethicon gets OK for handheld biopsy unit
Ethicon Endo-Surgery has received Food and Drug Administration marketing clearance for a handheld version of its Mammotome minimally invasive breast-biopsy device. The new unit, called Mammotome Hand Held, will be available Sept. 20, according to the
Ethicon Endo-Surgery has received Food and Drug Administration marketing clearance for a handheld version of its Mammotome minimally invasive breast-biopsy device. The new unit, called Mammotome Hand Held, will be available Sept. 20, according to the Cincinnati-based division of Johnson & Johnson. Ethicon expects Mammotome Hand Held will be employed in physicians offices, breast care centers, and hospitals. Using ultrasound guidance, Mammotome Hand Held vacuums out suspicious tissue for examination, according to the company. The original table-mounted Mammotome has been available in the U.S. since 1995 and has been used for more than 375,000 breast biopsies.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
